​

Funding Round

Series A - Octant Bio

Series A - Octant Bio

Investment Firm

Overview

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Announced Date

May 21, 2020

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Andreessen Horowitz

Andreessen Horowitz

Andreessen Horowitz is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorFifty Years
Participant Investor8VC
Participant InvestorAllen & Company
Participant InvestorSV Angel
Participant InvestorAndreessen Horowitz

Round Details and Background

Octant Bio raised $30000000 on 2020-05-21 in Series A

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 18, 2017
Seed Round - Octant Bio
7-5.0M
May 21, 2020
Series A - Octant Bio
7-30.0M
Apr 28, 2022
Series B - Octant Bio
8-80.0M

Recent Activity

There is no recent news or activity for this profile.